PROFILE

GutCRINE Pharmabiotics is a preclinical stage biotech company
– a spinout from University of Copenhagen (UCPH)

Founded in 2023 by seed funding from Eir Ventures and UCPH Ventures

UCPH owns IPR with GutCRINE having exclusive license rights for commercialization of inventions

The company is based on seminal discoveries in Professor Oluf Pedersen’s research team at UCPH of the human gut microbiome being an endocrine organ that is releasing polypeptide hormones regulating host metabolism

GutCRINE Pharmabiotics is a preclinical
stage biotech company – a spinout from
University of Copenhagen (UCPH)

Founded in 2023 by seed funding from
Eir Ventures and UCPH Ventures

UCPH owns IPR with GutCRINE
having exclusive license rights for
commercialization of inventions

The company is based on seminal discoveries in Professor Oluf Pedersen’s research team at UCPH of the human gut microbiome being an endocrine organ that is releasing polypeptide hormones regulating host metabolism